Drug absorption studies of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport
Introduction
In oral drug delivery programs, ester prodrugs are commonly used to enhance membrane permeation and transepithelial transport of hydrophilic drugs by increasing the lipophilicity of the parent compound, resulting in enhanced transmembrane transport by passive diffusion (Balant et al., 1990, Taylor, 1996). Acyloxyalkyl ester derivatives have, for instance, been introduced to increase oral bioavailability of phosphate or phosphonate compounds (Friis and Bundgaard, 1996). After absorption, the parent compound is expected to be released in the plasma through either enzymatic or chemical cleavage of the prodrug. This interesting approach can however be jeopardized if the prodrug is poorly resistant to esterase activity: rapid intracellular conversion of the prodrug by esterases inside the mucosal cells will result in the entrapment of the hydrophilic parent compound in the intestinal mucosa. Previous studies with the Caco-2 model conducted in our laboratory have shown that esterase mediated degradation of bis(pivaloyloxymethyl)-PMEA, a bis-ester prodrug of the antiviral compound phosphonylmethoxyethyladenine (PMEA), inside the cells was responsible for very high intracellular entrapment of negatively charged metabolites of bis(POM)-PMEA, thus diminishing the efficiency of the prodrug used (Annaert et al., 1997).
The objective of this report was to study the influence of metabolism on the transepithelial transport of ester prodrugs of a neutral compound in the Caco-2 system. Caco-2 monolayers are generally accepted as an in vitro model for drug transport studies as these cells have been shown to express most of the enzymatic, functional and morphological characteristics of the intestinal mucosa (Hidalgo et al., 1989, Audus et al., 1990, Hilgers et al., 1990, Gan et al., 1994). The Caco-2 system has already been used in several studies to characterise the biomembrane permeation of ester prodrugs (Hovgaard et al., 1995).
In this study, prednisolone acetate (lipophilic prodrug) and hemisuccinate (hydrophilic prodrug) were chosen as model prodrugs of a neutral compound, prednisolone. In addition to transport studies, esterase mediated degradation in homogenates of Caco-2 cells was compared to degradation in tissue homogenates from various sites in the GI tract of rat and pig using p-nitrophenyl acetate as a model substrate. These species were chosen as rats are commonly being used in drug bioavailability studies, while pigs are considered as the most suitable animal model for oral drug delivery since it resembles the human situation with respect to anatomy and physiology (Kararli, 1995, Gardner et al., 1996).
Section snippets
Reagents
Hanks' balanced salt solution, Dulbecco's Modified Eagle Medium (DMEM) containing glutaMAX™, N-[2-hydroxyethyl]piperazine-N-ethanesulfonic acid (HEPES), 0.05% trypsin and 0.02% EDTA in PBS, non-essential amino acids (NEAA), penicillin-streptomycin (10 000 IU/ml—10 000 μg/ml) and fetal bovine serum were from Gibco BRL (N.V. Life Technologies, Paisley, UK). MeOH and CH3CN were from BDH, Poole, UK. NaH2PO4, acetic acid, and sodium fluorescein were purchased from UCB, Leuven, Belgium; p-nitrophenyl
Results and discussion
The design of ester prodrugs with increased lipophilicity is one approach to enhance transport across membranes and to increase the oral bioavailability of charged compounds. One of the prerequisites of an efficient prodrug ester is that the drug is eventually released, be it enzymatically or chemically. For a charged parent drug, however, it may be possible that, if resistance to esterase mediated cleavage of the prodrug moiety is too low, metabolism in the intestinal cells by intracellular
Acknowledgements
This study was supported by a grant from the Fonds voor Wetenschappelijk Onderzoek – Vlaanderen (FWO, Belgium). P. Annaert acknowledges the receipt of a fellowship from the Flemish Institute for the promotion of scientific-technological research in the industry (IWT). The technical assistance of Ing. H. Herbots is greatly acknowledged.
References (15)
- et al.
Prodrugs of phosphates and phosphonates: novel lipophilic α-acyloxyalkyl ester derivatives of phosphate- or phosphonate containing drugs masking the negative charges of these groups
Eur. J. Pharm. Sci.
(1996) - et al.
Oral absorption of 21-corticosteroid esters: a function of aqueous stability and intestinal enzyme activity and distribution
J. Pharm. Sci.
(1986) - et al.
Characterisation of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
Gastroenterology
(1989) - et al.
Protein measurement with the Folin phenol reagent
J. Biol. Chem.
(1951) Improved passive oral drug delivery via prodrugs
Adv. Drug Deliv. Rev.
(1996)- et al.
Transport, uptake and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2- phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa (Caco-2)
Pharm. Res.
(1997) - et al.
The use of cultured epithelial and endothelial cells for drug transport and metabolism studies
Pharm. Res.
(1990)
Cited by (56)
Self-assembled nanoformulation of methylprednisolone succinate with carboxylated block copolymer for local glucocorticoid therapy
2018, Colloids and Surfaces B: BiointerfacesCitation Excerpt :An almost 3-fold increase in the overall effect of TBC-COOH/MPS on viability of SH-SY5Y cells could be explained by enhanced cellular uptake of the mixed micelles compared with the unbound glucocorticoid. MPS is considered to have a relatively low permeability across cellular membranes at submillimolar level [42]. Increased diffusion of MPS across the plasma membrane at higher millimolar concentrations seems to promote its cytotoxicity (Fig. 4).
Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate
2017, Journal of Pharmaceutical SciencesThe Effect of Food on the Intraluminal Behavior of Abiraterone Acetate in Man
2016, Journal of Pharmaceutical SciencesCitation Excerpt :Several mechanisms have been described by which food can influence the intestinal absorption of a compound including an increased solubility, a delayed gastric emptying, as well as an increase in the intestinal stability of the compound.3-6 The influence of food on the bioavailability of different ester prodrugs has been demonstrated in several studies.7-9 Premature chemical or enzymatic hydrolysis in the intestine can indeed jeopardize the intended increased absorption of the ester.10,11
Applications of a 7-day Caco-2 cell model in drug discovery and development
2014, European Journal of Pharmaceutical Sciences